EDS ECHO Pediatrics Australia Application

EDS ECHO Pediatrics Australia

This is a free program for healthcare professionals worldwide, across all disciplines who want to improve their ability to care for people with EDS, HSD and associated symptoms and conditions.

Please complete the application form below to apply for a place on the EDS ECHO Pediatrics, Australia Program.

EDS ECHO Pediatrics, Australia – Program Details:

EDS ECHO Pediatrics is a free program for Healthcare Professionals worldwide, across all disciplines who want to improve their ability to care for children and younger people with EDS, HSD, and associated symptoms and conditions.

The programs consist of expert presentations and case-based interactive sessions delivered virtually via the Zoom platform. Each session is 1hr 30 minutes in length and is led by Dr. Louise Tofts.

Participants are encouraged to share their cases and questions in the sessions and are guided to further educational materials and support.

Participants who are accepted into the program are asked to attend as much of the program as possible to get the most out of their place. All participants are encouraged to share their cases and questions in the sessions and are guided to further educational material and support. CME/CEU/CE credits or a certificate of attendance are available to healthcare professionals at no charge. Credits are awarded at 1 per 60 minutes of live session activity.

 Program: EDS ECHO Pediatrics Australia Clinical Lead: Dr. Louise Tofts
Date & Time: Thursdays at 7:00pm – 8:30pm (Sydney)
Session 1 – Introduction to Hypermobility in Younger Children October 13, 2022
Session 2 – Differential Diagnosis in Younger Children: Rare Ehlers-Danlos Syndromes, Other Conditions October 20, 2022
Session 3 – Gross Motor and Musculoskeletal Issues, Physiotherapy Management October 27, 2022
Session 4 – Fine Motor and Functional Issues, Occupational Therapy Management November 3, 2022
Session 5 – Foot and Lower Limb Biomechanics, Podiatric Management November 10, 2022
Session 6 – Developmental Emotional and Behavioural Issues, Psychological Management November 17, 2022
Session 7 – Persistent Pain – Multidisciplinary Management November 24, 2022
Session 8 – Disabling Fatigue – Multidisciplinary Management December 1, 2022


PLEASE NOTE – Session dates and topics are subject to change.

Please visit https://www.worldtimebuddy.com, or your preferred time zone converter to confirm the correct start time in your location.

The program content is currently only presented in English.

This is a virtual program, you will be sent a link to join the sessions which are run via the zoom platform. Once signed up, we ask that you attend a minimum of 5 out of the 8 sessions. You can catch up with the sessions you miss by watching our password protected recordings online. For all queries regarding EDS ECHO, please email our EDS ECHO Program Coordinator.

Each EDS ECHO session is worth 1.5 CME/CEU/CE credits, you will be sent a link to claim these after each session.

For more information, visit our dedicated EDS ECHO Pediatrics web page.

Please complete and submit the following information to apply for a place on the program:

Project ECHO

In support of improving patient care, this activity has been planned and implemented by The Ehlers-Danlos Society and Project ECHO®.  Project ECHO® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

EDS ECHO

AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™ per 60 minutes. Clinicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.

None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Alan Hakim, MD; Stacey Simmonds; Paul Gardener; Owen Moore; Lara Bloom, Prof; Clair Francomano, MD; Jane Schubart, MD; Rebecca Bascom, MD; Shani Weber; Louise Tofts, MD;

 

The following planners / presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company:

Nature of Relationship Name of Ineligible Company
Dr. Clair Francomano Consultant
Other Financials

Acer Therapeutics
Scientific Advisory Board, Kyani International

All of the relevant financial relationships listed for [this/these individual(s)] have been mitigated.